IBIO iBio, Inc.

iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.

$2.02  -0.01 (-0.25%)
As of 02/24/2021 13:21:19 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
01/04/2011
216,009,931
22,170,502
$436,340,061
0.00%
SEC Edgar Online
10-Q
10-K
451033203
US4510332038
BG43QY2

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-18.08
3.98
187.19
-22.24%
-1,024.28%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy